Tabbal H, Septier A, Mathieu M, Drelon C, Rodriguez S, Djari C, et al. EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness. Br J Cancer. 2019;121:384-394 pubmed publisher

Chen P, Wu J, Shu Y, Jiang H, Zhao X, Qian H, et al. Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction. Clin Sci (Lond). 2018;132:1417-1433 pubmed publisher

Wang Y, Cornett A, King F, Mao Y, Nigsch F, Paris C, et al. Evidence-Based and Quantitative Prioritization of Tool Compounds in Phenotypic Drug Discovery. Cell Chem Biol. 2016;23:862-874 pubmed publisher

Chan N, Lim T. Cytoplasmic nucleophosmin has elevated T199 phosphorylation upon which G2/M phase progression is dependent. Sci Rep. 2015;5:11777 pubmed publisher

Ojo K, Gillespie J, Riechers A, Napuli A, Verlinde C, Buckner F, et al. Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy. Antimicrob Agents Chemother. 2008;52:3710-7 pubmed publisher